Table 1

Clinical characteristics for each study-group of offsprings and controls.


IR
NIR
Controls
p Value

Sex (M/F)
16/9
18/7
16/9

Age (years)
49,12 ± 6,68
49,80 ± 6,53
53,69 ± 3,72
0,190
BMI (kg/m2)
25.41 ± 4.67
25.50 ± 3.69
25.09 ± 2.23
0,120
Glycemia '0 (mg/dl)
93,375 ± 11,06
99,66 ± 1,30
94,00 ± 6,15
0,095
Glycemia '120 (mg/dl)
97,62 ± 17,45
90,00 ± 26,60
92,66 ± 18,22
0,095
Fasting plasma insulin (uU/ml)
17,95 ± 6,35
7,66 ± 0,50
7,16 ± 0,21
0,000
HOMA index
4,41 ± 0,80
1.83 ± 0,12
1,45 ± 0,25

SP (mmHg)
123,20 ± 3,70
122,60± 6,35
120.20 ± 7.09
0,013
DP(mmHg)
80,00 ± 3,16
79,80± 3,56
78.80 ± 4.90
0,014
HR (bpm)
74.75 ± 4.57
70.25 ± 4.11
68.50 ± 5.92
0,011

SP: systolic pressure, DP: diastolic pressure, HR: heart rate, BMI: body mass index, HOMA-I: the homeostasis model assessment-index, IR: insulin resistant offsprings of type 2 diabetic patients, NIR: non insulin resistant offsprings of type 2 diabetic patients.

Fiorentini et al. Cardiovascular Diabetology 2005 4:15   doi:10.1186/1475-2840-4-15